Molecular Imaging: A Useful Tool for the Development of Natural Killer Cell-Based Immunotherapies

Abstract

Molecular imaging is a relatively new discipline that allows visualization, characterization, and measurement of the biological processes in living subjects, including humans, at a cellular and molecular level. The interaction between cancer cells and natural killer (NK) cells is complex and incompletely understood. Despite our limited knowledge, progress in the search for immune cell therapies against cancer could be significantly improved by dynamic and non-invasive visualization and tracking of immune cells and by visualization of the response of cancer cells to therapies in preclinical and clinical studies. Molecular imaging is an essential tool for these studies, and a multimodal molecular imaging approach can be applied to monitor immune cells in vivo, for instance, to visualize therapeutic effects. In this review, we discuss the usefulness of NK cells in cancer therapies and the preclinical and clinical usefulness of molecular imaging in NK cell-based therapies. Furthermore, we discuss different molecular imaging modalities for use with NK cell-based therapies, and their preclinical and clinical applications in animal and human subjects. Molecular imaging has contributed to the development of NK cell-based therapies against cancers in animal models and to the refinement of current cell-based cancer immunotherapies. Developing sensitive and reproducible non-invasive molecular imaging technologies for in vivo NK cell monitoring and for real-time assessment of therapeutic effects will accelerate the development of NK cell therapies.

A new bioluminescent reporter system to study the biodistribution of systematically injected tumor-derived bioluminescent extracellular vesicles in mice

“…In vivo trafficking of EVs in animal models is not well understood. Bioluminescence imaging (BLI) is a powerful method for cell tracking in small animals (such as mice) over time, without requiring the subject to be euthanized [ 33 , 34 ]. Research involving BLI for monitoring EV distribution without exogenous dyes is very limited [ 29 , 31 , 35 , 36 ].…”

Novel alternatives to extracellular vesicle-based immunotherapy – exosome mimetics derived from natural killer cells

“…Strong antitumour activity of NK-EM might be due to their biological contents inherited from the parental NK cells. Perforin and granzyme B are the core molecules required for NK cell-mediated tumour killing and the death-receptor pathways (involving FasL and TRAIL) are commonly used for the killing [2,36,50]. Perforin triggers the intrinsic pathway and elevates the release of cytochrome-c [36,51].…”

Immunotherapy in Non-Small-Cell Lung Cancer: A Bridge Between Research and Clinical Practice

“…Therefore, it is attempting to define a quantitative biomarker that can assist in the selection and treatment of patients who undergo such therapies, modulating treatment dosage and effectiveness through the dynamic and noninvasive visualization of the immune response to the drugs in question [145][146][147].…”